Analysis

Generic Drug Price-Fixing MDL Fuels Worries For Defendants

Law360, Philadelphia (May 23, 2017, 5:20 PM EDT) -- The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania’s Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous defendants could make it harder for individual companies to avoid getting more deeply embroiled in the litigation.

The Judicial Panel on Multidistrict Litigation in April sent 10 lawsuits accusing Mylan NV, Sandoz Inc. and other pharmaceutical companies of fixing prices on generic drugs to U.S. District Judge...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.